Schedule 3 CBD products are coming soon
If you haven’t heard, the TGA recently down-scheduled low-dose cannabidiol (CBD) to a Schedule 3 classification. This means Australians can start purchasing low-dose CBD products over the counter without a prescription. However, with no TGA-approved products currently on the Australian Register of Therapeutic Goods (ARTG) that meet the S3 criteria, we’re excited to soon introduce Australia’s first S3 CBD products on the market.
While there are currently no CBD products on the market that fit into the Schedule 3 category, the increase in consumer demand for Medical Cannabis has skyrocketed, following the TGA’s announcement.
After the legislation change, consumers flocked to Pharmacies asking for more information on how to access low-dose cannabinoid oil, CBD.